Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Stahl, Stephen M.
2014.
Mechanism of action of the SPARI vilazodone: serotonin 1A partial agonist and reuptake inhibitor.
CNS Spectrums,
Vol. 19,
Issue. 2,
p.
105.
Zohar, Joseph
Stahl, Stephen
Moller, Hans-Jurgen
Blier, Pierre
Kupfer, David
Yamawaki, Shigeto
Uchida, Hiroyuki
Spedding, Michael
Goodwin, Guy M.
and
Nutt, David
2015.
A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature.
European Neuropsychopharmacology,
Vol. 25,
Issue. 12,
p.
2318.
Culpepper, Larry
Muskin, Philip R.
and
Stahl, Stephen M.
2015.
Major Depressive Disorder: Understanding the Significance of Residual Symptoms and Balancing Efficacy with Tolerability.
The American Journal of Medicine,
Vol. 128,
Issue. 9,
p.
S1.
Stahl, Stephen M.
2015.
Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): enhancing serotonin release by combining serotonin (5HT) transporter inhibition with actions at 5HT receptors (5HT1A, 5HT1B, 5HT1D, 5HT7 receptors).
CNS Spectrums,
Vol. 20,
Issue. 2,
p.
93.
Frazer, Alan
and
Blier, Pierre
2016.
A Neuroscience-Based Nomenclature (NbN) for Psychotropic Agents.
International Journal of Neuropsychopharmacology,
Vol. 19,
Issue. 8,
p.
pyw066.
diagnostické aspekty, měli bychom zhodnotit
and
léčby včetně adherence., hlavně komorbiditu a adekvátnost dosavadní
2016.
Pharmacoresistant depression - what is the next step?.
Psychiatrie pro praxi,
Vol. 17,
Issue. 3,
p.
92.
Stahl, Stephen M.
2016.
Using neuroscience for naming psychotropic drugs.
CNS Spectrums,
Vol. 21,
Issue. 3,
p.
219.
Ceskova, Eva
2016.
Current pharmacotherapy of depression – focused on multimodal/multifunctional antidepressants.
Expert Opinion on Pharmacotherapy,
Vol. 17,
Issue. 14,
p.
1835.
Blier, Pierre
Oquendo, Maria A
and
Kupfer, David J
2017.
Progress on the Neuroscience-Based Nomenclature (NbN) for Psychotropic Medications.
Neuropsychopharmacology,
Vol. 42,
Issue. 10,
p.
1927.
Bang‐Andersen, Benny
Bøgesø, Klaus P.
Kehler, Jan
and
Sánchez, Connie
2017.
Transporters as Drug Targets.
p.
21.
Kamarádová, Dana
2019.
Treatment of depression with prolonged form of trazodone.
Psychiatrie pro praxi,
Vol. 20,
Issue. 2,
p.
86.
Villas Boas, Gustavo Roberto
Boerngen de Lacerda, Roseli
Paes, Marina Meirelles
Gubert, Priscila
Almeida, Wagner Luis da Cruz
Rescia, Vanessa Cristina
de Carvalho, Pablinny Moreira Galdino
de Carvalho, Adryano Augustto Valladao
and
Oesterreich, Silvia Aparecida
2019.
Molecular aspects of depression: A review from neurobiology to treatment.
European Journal of Pharmacology,
Vol. 851,
Issue. ,
p.
99.
Evans, Elizabeth Jane
and
Trollor, Julian Norman
2021.
Mental Health, Intellectual and Developmental Disabilities and the Ageing Process.
p.
189.
Park, Seon-Cheol
and
Shen, Winston Wu-Dien
2023.
Tasman’s Psychiatry.
p.
1.
Ghallab, Youssef K.
and
Elassal, Omnia S.
2024.
Nutrition and Psychiatric Disorders.
p.
25.
Park, Seon-Cheol
and
Shen, Winston Wu-Dien
2024.
Tasman’s Psychiatry.
p.
4069.